ZNF124

gene
On this page

Also known as HZF16HZF-16

Summary

ZNF124 (zinc finger protein 124, HGNC:12907) is a protein-coding gene on chromosome 1q44, encoding Zinc finger protein 124 (Q15973). May be involved in transcriptional regulation.

This gene encodes a protein with an amino-terminal KRAB-A box and multiple repeated Kruppel-type (C2H2) zinc finger motifs at its carboxy terminus. The encoded protein may function as a transcription factor. Expression of this gene is increased after vascular endothelial growth factor (VEGF) stimulation in human leukemia cell lines and results in inhibition of apoptotic cell death induced by irradiation or exposure to etoposide. Alternative splicing results in multiple transcript variants encoding distinct proteins.

Source: NCBI Gene 7678 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 56 total — 1 pathogenic
  • MANE Select transcript: NM_001297568

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:12907
Approved symbolZNF124
Namezinc finger protein 124
Location1q44
Locus typegene with protein product
StatusApproved
AliasesHZF16, HZF-16
Ensembl geneENSG00000196418
Ensembl biotypeprotein_coding
OMIM194631
Entrez7678

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 5 protein_coding, 2 protein_coding_CDS_not_defined

ENST00000340684, ENST00000472531, ENST00000476312, ENST00000491356, ENST00000491848, ENST00000543802, ENST00000915841

RefSeq mRNA: 5 — MANE Select: NM_001297568 NM_001243740, NM_001297567, NM_001297568, NM_001297569, NM_003431

CCDS: CCDS31089, CCDS58067, CCDS73057, CCDS76278

Canonical transcript exons

ENST00000543802 — 4 exons

ExonStartEnd
ENSE00002230988247154989247157403
ENSE00002714766247171848247172020
ENSE00003545914247159687247159813
ENSE00003609686247159006247159066

Expression profiles

Bgee: expression breadth ubiquitous, 234 present calls, max score 94.68.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0272 / max 18.4945, expressed in 4 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
185010.02724

Top tissues by expression

282 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
colonic epitheliumUBERON:000039794.68gold quality
secondary oocyteCL:000065589.62gold quality
calcaneal tendonUBERON:000370189.41gold quality
right testisUBERON:000453487.99gold quality
left testisUBERON:000453387.87gold quality
superficial temporal arteryUBERON:000161485.74gold quality
cortical plateUBERON:000534385.32gold quality
testisUBERON:000047384.16gold quality
jejunal mucosaUBERON:000039984.10gold quality
mucosa of sigmoid colonUBERON:000499383.84gold quality
cauda epididymisUBERON:000436083.12gold quality
colonic mucosaUBERON:000031782.96gold quality
adrenal tissueUBERON:001830382.92gold quality
tendonUBERON:000004381.81gold quality
caput epididymisUBERON:000435881.78gold quality
corpus epididymisUBERON:000435981.77gold quality
monocyteCL:000057681.43gold quality
mononuclear cellCL:000084280.95gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099180.79gold quality
leukocyteCL:000073880.63gold quality
mucosa of transverse colonUBERON:000499180.36gold quality
ganglionic eminenceUBERON:000402380.27gold quality
bone marrow cellCL:000209280.01gold quality
corpus callosumUBERON:000233679.43gold quality
rectumUBERON:000105279.29gold quality
endometriumUBERON:000129579.29gold quality
tonsilUBERON:000237279.16gold quality
oocyteCL:000002378.58gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047378.28gold quality
mammary ductUBERON:000176576.99gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no4.28

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): STAT1

miRNA regulators (miRDB)

113 targeting ZNF124, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-4768-5P100.0069.492861
HSA-MIR-3925-3P100.0069.951237
HSA-MIR-4262100.0073.263931
HSA-MIR-5692A100.0074.406850
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-181A-5P99.9972.962995
HSA-MIR-181B-5P99.9972.972996
HSA-MIR-181C-5P99.9972.952996
HSA-MIR-181D-5P99.9973.042997
HSA-MIR-428299.9975.366408
HSA-MIR-366299.9973.825684
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-314899.9775.066478
HSA-MIR-60799.9773.625593
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-55999.9572.283609
HSA-MIR-548AB99.9571.313488
HSA-MIR-651-3P99.9473.485177
HSA-MIR-548A-5P99.9471.273482
HSA-MIR-548AD-5P99.9471.233502
HSA-MIR-548AE-5P99.9471.233502
HSA-MIR-548AK99.9471.243488
HSA-MIR-548AM-5P99.9471.243488
HSA-MIR-548AP-5P99.9471.143489

Literature-anchored findings (GeneRIF, showing 1)

  • RNA-Seq evidence for lung tissue-specific monoallelic expression of ZNF124, located 363 kb upstream of the GCSAML somatic (secondary), imprinted differentially methylated region (iDMR). The ZNF124 locus has no overlapping hemimethylated CGIs in normal tissues, including lung tissue The GCSAML iDMR might regulate the lung tissue-specific, monoallelic expression of ZNF124. In the placenta, ZNF124 is biallelically expressed. (PMID:29545821)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
mus_musculusZfp78ENSMUSG00000055150
rattus_norvegicusENSRNOG00000083797
drosophila_melanogasterCG2712FBGN0024975
drosophila_melanogasterPhsFBGN0036522
drosophila_melanogasterCG3281FBGN0260741

Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300)

Protein

Protein identifiers

Zinc finger protein 124Q15973 (reviewed: Q15973)

Alternative names: Zinc finger protein HZF-16

All UniProt accessions (2): Q15973, J3QKQ6

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (5)

UniProt IDNamesCanonical?
Q15973-31yes
Q15973-42
Q15973-13, HZF-16.2
Q15973-24, HZF-16.1
Q15973-55

RefSeq proteins (5): NP_001230669, NP_001284496, NP_001284497, NP_001284498, NP_003422 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096, PF01352

UniProt features (14 total): zinc finger region 8, splice variant 4, chain 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q15973-F176.710.41

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 161 (showing top): BROWNE_HCMV_INFECTION_30MIN_DN, BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN, LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP, MODULE_123, DODD_NASOPHARYNGEAL_CARCINOMA_UP, FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN, MODULE_98, chr1q44, TGGAAA_NFAT_Q4_01, SANSOM_APC_TARGETS, MODULE_198, DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, LEE_BMP2_TARGETS_UP, WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
transcription cis-regulatory region binding1
chromatin1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
nucleic acid binding1
transition metal ion binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

394 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF124TMEM128Q5BJH2400
ZNF124TBC1D3GQ6DHY5325
ZNF124TMEM179Q6ZVK1323
ZNF124OR2A7Q96R45322
ZNF124FAM81AQ8TBF8310
ZNF124GCSAMLQ5JQS6297
ZNF124PLCXD2Q0VAA5293
ZNF124YES1P07947277
ZNF124SPATA3Q8NHX4273
ZNF124SCML4Q8N228272
ZNF124TXNL4AP83876270
ZNF124GABPB2Q8TAK5270
ZNF124NRIP2Q9BQI9264
ZNF124CDYL2Q8N8U2261
ZNF124DCUN1D4Q92564253

IntAct

205 interactions, top by confidence:

ABTypeScore
ZNF124KRTAP5-9psi-mi:“MI:0915”(physical association)0.720
ZNF124KRTAP10-8psi-mi:“MI:0915”(physical association)0.720
KRTAP10-9ZNF124psi-mi:“MI:0915”(physical association)0.720
ZNF124TRAF1psi-mi:“MI:0915”(physical association)0.720
MDFIZNF124psi-mi:“MI:0915”(physical association)0.720
KRTAP5-9ZNF124psi-mi:“MI:0915”(physical association)0.720
KRTAP10-8ZNF124psi-mi:“MI:0915”(physical association)0.720
TRAF1ZNF124psi-mi:“MI:0915”(physical association)0.720
ZNF124MDFIpsi-mi:“MI:0915”(physical association)0.720
FSD2ZNF124psi-mi:“MI:0915”(physical association)0.560
MEOX2ZNF124psi-mi:“MI:0915”(physical association)0.560
ZNF124CCNDBP1psi-mi:“MI:0915”(physical association)0.560
TCF4ZNF124psi-mi:“MI:0915”(physical association)0.560
ZNF124KRTAP10-7psi-mi:“MI:0915”(physical association)0.560
GOLGA2ZNF124psi-mi:“MI:0915”(physical association)0.560
KRT31ZNF124psi-mi:“MI:0915”(physical association)0.560
KRT40ZNF124psi-mi:“MI:0915”(physical association)0.560
ZNF124SYCE1psi-mi:“MI:0915”(physical association)0.560
ZNF124KRTAP4-2psi-mi:“MI:0915”(physical association)0.560

BioGRID (71): ZNF124 (Two-hybrid), ZNF124 (Two-hybrid), ZNF124 (Two-hybrid), ZNF124 (Two-hybrid), ZNF124 (Two-hybrid), ZNF124 (Two-hybrid), ZNF124 (Two-hybrid), CCNDBP1 (Two-hybrid), TSGA10 (Two-hybrid), KRTAP4-2 (Two-hybrid), SYCE1 (Two-hybrid), SSX2IP (Two-hybrid), FSD2 (Two-hybrid), KRT40 (Two-hybrid), KRTAP10-7 (Two-hybrid)

ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A2RRD8, A6NHJ4, A6NP11, B4DX44, O75346, O95780, P0CB33, P21506, P51508, P52738, Q0D2J5, Q0VGE8, Q12901, Q13360, Q14593, Q15973, Q2M218, Q2M3X9, Q2VY69, Q3SXZ3, Q5HY98, Q5RCJ2, Q5VIY5, Q6J6I6, Q7L2R6, Q86XU0, Q86Y25, Q8IW36, Q8IYN0, Q8IYX0, Q8N782, Q8N883, Q8N9Z0, Q8NDP4, Q95K49, Q969W8, Q96H40, Q96N58

Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 58 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Keratinization1117.5×2e-09

Disease & clinical

Clinical variants and AI predictions

ClinVar

56 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance49
Likely benign0
Benign1

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
3391873GRCh37/hg19 1q43-44(chr1:243204376-249224684)x1Pathogenic

SpliceAI

772 predictions. Top by Δscore:

VariantEffectΔscore
1:247171843:CTCA:Cdonor_loss1.0000
1:247171844:TCA:Tdonor_loss1.0000
1:247171845:CACC:Cdonor_loss1.0000
1:247171846:A:ACdonor_gain1.0000
1:247171846:AC:Adonor_gain1.0000
1:247171847:C:CCdonor_gain1.0000
1:247171847:CC:Cdonor_gain1.0000
1:247159682:CTTA:Cdonor_loss0.9900
1:247159683:TTA:Tdonor_loss0.9900
1:247159685:A:Cdonor_loss0.9900
1:247159686:C:CAdonor_loss0.9900
1:247171847:CCA:Cdonor_gain0.9900
1:247157122:C:CCacceptor_gain0.9800
1:247159001:ATTAC:Adonor_loss0.9800
1:247159002:TTA:Tdonor_loss0.9800
1:247159003:TACCT:Tdonor_loss0.9800
1:247159005:CC:Cdonor_loss0.9800
1:247159081:C:Tacceptor_gain0.9800
1:247171847:CCAT:Cdonor_gain0.9800
1:247158999:AAATT:Adonor_loss0.9700
1:247159000:AATTA:Adonor_loss0.9700
1:247159797:T:TGacceptor_gain0.9700
1:247171860:T:TAdonor_gain0.9700
1:247159006:C:Adonor_loss0.9600
1:247159067:C:CCacceptor_gain0.9600
1:247159685:A:ACdonor_gain0.9600
1:247159686:C:CCdonor_gain0.9600
1:247171847:CCATT:Cdonor_gain0.9600
1:247159064:TTCCT:Tacceptor_loss0.9500
1:247159065:TCCT:Tacceptor_loss0.9500

AlphaMissense

2361 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:247157061:G:CF187L0.994
1:247157061:G:TF187L0.994
1:247157063:A:GF187L0.994
1:247156641:A:CF327L0.993
1:247156641:A:TF327L0.993
1:247156643:A:GF327L0.993
1:247156977:G:CF215L0.993
1:247156977:G:TF215L0.993
1:247156979:A:GF215L0.993
1:247156893:G:CF243L0.992
1:247156893:G:TF243L0.992
1:247156895:A:GF243L0.992
1:247156725:G:CF299L0.990
1:247156725:G:TF299L0.990
1:247156727:A:GF299L0.990
1:247156809:G:CF271L0.987
1:247156809:G:TF271L0.987
1:247156811:A:GF271L0.987
1:247157044:A:GL193P0.987
1:247157022:A:CH200Q0.984
1:247157022:A:TH200Q0.984
1:247156938:G:CH228Q0.979
1:247156938:G:TH228Q0.979
1:247157034:A:CH196Q0.977
1:247157034:A:TH196Q0.977
1:247156686:A:CH312Q0.976
1:247156686:A:TH312Q0.976
1:247159734:A:GL37P0.976
1:247156698:A:CH308Q0.975
1:247156698:A:TH308Q0.975

dbSNP variants (sampled 300 via entrez): RS1000084169 (1:247163587 C>G,T), RS1000114198 (1:247124895 C>G,T), RS1000163293 (1:247121485 T>C), RS1000274956 (1:247139908 T>C,G), RS1000330848 (1:247128291 G>A), RS1000435083 (1:247157966 A>T), RS1000615109 (1:247141547 C>T), RS1000668148 (1:247126158 C>A,T), RS1000720164 (1:247126016 C>A,T), RS1000779025 (1:247167598 A>G), RS1000819173 (1:247167287 A>G), RS1000857461 (1:247145987 C>A), RS1000864253 (1:247151275 C>G,T), RS1000870837 (1:247163321 A>AG), RS1000885191 (1:247168727 G>A)

Disease associations

OMIM: gene MIM:194631 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST000977_3Alcohol dependence4.000000e-06

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

33 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
trichostatin Aaffects cotreatment, increases expression2
Cyclosporinedecreases expression2
bisphenol Faffects cotreatment, increases expression1
TAK-243increases sumoylation1
bisphenol Aincreases expression1
sodium arsenitedecreases expression1
CGP 52608affects binding, increases reaction1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideincreases expression, affects cotreatment1
abrinedecreases expression1
dorsomorphinaffects cotreatment, increases expression1
jinfukangdecreases expression1
PCI 5002affects cotreatment, increases expression1
Resveratrolaffects cotreatment, increases expression1
Sunitinibincreases expression1
Acetaminophenincreases expression1
Benzo(a)pyreneincreases methylation1
Cadmiumincreases abundance, increases expression1
Coumestroldecreases expression1
Dexamethasoneaffects cotreatment, increases expression1
Diazinonincreases methylation1
Formaldehydeincreases expression1
Golddecreases expression1
Indomethacinaffects cotreatment, increases expression1
Plant Extractsaffects cotreatment, increases expression1
Tretinoinincreases expression1
Tunicamycindecreases expression1
Valproic Aciddecreases expression1
Zincaffects cotreatment, increases expression1
1-Methyl-3-isobutylxanthineincreases expression, affects cotreatment1
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxidedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): alcohol dependence